期刊文献+

乌司他丁对严重脓毒症患者凝血功能的影响 被引量:5

Effects of ulinastatin on coagulation function in patients with severe sepsis
在线阅读 下载PDF
导出
摘要 目的探讨乌司他丁对严重脓毒症患者凝血功能的影响与治疗严重脓毒症的效果。方法收集我院ICU2013年5月~2015年1月收治的严重脓毒症患者92例,随机分为乌司他丁治疗组(46例)和对照组(46例)。两组患者均予液体复苏、抗感染等治疗,治疗组在对照组治疗的基础上加用乌司他丁20 0000 U,1次/8 h,共5 d,观察治疗前后两组血小板(PLT)、凝血酶原时间(PT)、活化的部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、凝血酶时间(TT)的变化。观察两组患者ICU停留时间及28 d生存率。结果对照组第2天和第5天PLT和FIB均明显下降,与治疗前比较,差异有统计学意义(P〈0.05),PT、APTT、TT与治疗前比较,差异无统计学意义(P〉0.05);治疗组第2天与治疗前凝血功能指标比较,差异无统计学意义(P〉0.05),第5天PT、APTT、TT缩短,PLT和FIB均增高(P〈0.05);第5天治疗组与对照组同期比较,治疗组PLT和FIB均有增高,PT、APTT、TT均缩短,差异有统计学意义(P〈0.05);治疗组患者ICU停留时间少于对照组(P〈0.05),治疗组患者28 d生存率高于对照组(P〈0.05)。结论乌司他丁可改善严重脓毒症患者凝血功能及预后。 Objective To analyze the effects of ulinastatin on coagulation function in patients with severe sepsis,and to explore the clinical efficacy of ulinastatin in patients with severe sepsis. Methods From May 2012 to September 2014,a total of 92 patients with severe sepsis in the ICU were enrolled. They were divided into the treatment group(n=46) and the control group(n=46).All the patients were given routine therapy by anti-infection and fluid resuscitation.The treatment group was treated ulinastatin 20 0000 U one time per eight hours on the basis of conventional therapy for 5 days.PLT,PT,APTT and FIB were observed before and after treatment in two groups.The time of ICU stay and the 28-day survival rate were observed in two groups. Results PLT and FIB declined significantly in the control group on the 2nd and 5thday(P〈0.05).In the treatment group,When compared with the before treatment,PLT,PT,APTT,TT and FIB was same on the 2ndday(P〉0.05), In the tneatment group, coagulation function had no statisically significant difference that than before treatment on the 2ndday(P〉0.05),but PLT, PT,APTT and FIB were significantly improved on the 5 d(P〈0.05).On the 5thday,PLT,PT,APTT and FIB were improved with the control group at the same time point(P〈0.05).In the treatment group,the time of ICU stay was shorter than the control group,but the 28-day survival rate was higher(P〈0.05).Conclusion Ulinastatin might improve coagulation function and increase survival rate of patients with severe sepsis.
出处 《中国当代医药》 2016年第1期149-151,共3页 China Modern Medicine
基金 广西壮族自治区卫生厅计划课题(Z2014547)
关键词 脓毒症 乌司他丁 凝血功能 Sepsis Coagulation function Ulinastatin
  • 相关文献

参考文献16

  • 1Nakatani K,Takeshita S,Tsujimoto H,et al.Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury[J] .J Leukoc Biol, 2001,69 ( 2 ) : 241- 247.
  • 2Lin SD,Endo R,Kuroda H,et al.Plasma and urine levels of urinary trypsin inhibitor in patients with ehronie liver diseases and hepatoeellular eareinoma[J].J Gastroenterol Hepatol, 2004,19(3 ) : 327-332.
  • 3Briegel J, Mohnle P.lntemational guidelines of the Surviving Sepsis Campaign : update 2012[J].Anaesthesist,2013, 62(4) : 304-309.
  • 4宋振举,童朝阳.严重脓毒症免疫调节治疗:从免疫抑制走向免疫增强[J].中华急诊医学杂志,2014,23(4):365-368. 被引量:21
  • 5Bauer I,Bauer M,Raddatz A,et al.Influence of gender on stimulated cytokine response in patients with severe sep- sis[J].Anaesthesist, 2006,55 (5) : 515-527.
  • 6Soerensen KE, Olsen HG, Skovgaard K, et al.Disseminated intravascular coagulation in a novel porcine model of se- vere Staphylococcus aureus sepsis fulfills human clinical criteria[J].J Comp Pathol, 2013,149(4) : 463-474.
  • 7许晓巍,李岩,贡伟,赵英英,沈芸,史红潮,郑明芳,徐侃.脓毒症凝血功能异常的发生率和临床意义[J].临床急诊杂志,2010,11(4):232-233. 被引量:20
  • 8Kinasewitz GT,Yan SB, Basson B,et al.Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro- organism [ISRCTN74215569] [J].Crit Care, 2004,8 (2) : R82-90.
  • 9Yamaguchi Y,Ohshiro H,Nagao Y,et al.Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liv- er ischemia/reperfusion [J].J Surg Res, 2000,94 (2) :i 07 - 115.
  • 10曾凡杰,陈芬兰,陈少媚,彭娜,许献文.乌司他丁联合血必净注射液对脓毒性休克患者心肌损伤的保护作用[J].广东医学,2013,34(4):616-618. 被引量:50

二级参考文献90

共引文献165

同被引文献40

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部